[PDF] Top 20 <p>Bladder Dysfunction in Iranian Patients with Multiple Sclerosis</p>
Has 10000 "<p>Bladder Dysfunction in Iranian Patients with Multiple Sclerosis</p>" found on our website. Below are the top 20 most common "<p>Bladder Dysfunction in Iranian Patients with Multiple Sclerosis</p>".
<p>Bladder Dysfunction in Iranian Patients with Multiple Sclerosis</p>
... Patients were asked to fi ll the valid and reliable Persian version of the 8-item Actionable Bladder Symptom Screening Tool (ABSST) questionnaire. 14 The ABSST questionnaire includes eight questions with ... See full document
5
Molecular Analysis of rs2070744 and rs1799983 Polymorphisms of NOS3 Gene in Iranian Patients With Multiple Sclerosis
... This polymorphism causes diminished NOS3 enzyme activity and the c.-813C>T (rs2070744) polymorphism in the promoter region, where it has been found with reduced NOS3 promoter activity in vitro (Miyamoto et al., 1998; ... See full document
6
The effect of exercise therapy on cognitive functions in multiple sclerosis patients: A pilot study
... overactive bladder, and sexual ...MS patients is their cog- nitive impairment (4) ...MS patients face some degrees of cognitive difficulties in their dai- ly lives ...MS patients are young and ... See full document
9
Sexual Dysfunction in Iranian Azeri Women With Multiple Sclerosis: Levels and Correlates
... This study investigated the levels and correlates of SD in Iranian Azeri women with MS. Among the MS patients, 88.6% of women reported primary (83.3%), secondary (56.6%), and tertiary (36.6%) SD. The high ... See full document
7
Physical disability and bladder and sexual dysfunction: Interrelationships in women with multiple sclerosis
... Estimates of depressive synq)tomatology in people with disabihties have been reported as four times as high as for those without disabihties (Turner and Beiser 1990). The explanation for this is that difficulty ... See full document
313
RAGE p.82G>S Polymorphism Is Not Associated with the Risk of Multiple Sclerosis in Iranian Population
... MS patients in a Hungarian population ...of patients being significantly lower than that of the healthy subjects, which was obvious in individuals with genotype 82 ...MS patients, RAGE 82GS or 82SS ... See full document
8
Cognitive dysfunction in pediatric multiple sclerosis
... Most studies evaluating the attention domain considered several components of this function and used the Trail Mak- ing Test, the Symbol Digit Modalities Test, or the Continuous Performance Test. Complex aspects of ... See full document
8
Iranian consensus on use of vitamin D in patients with multiple sclerosis
... 2015) patients with serum 25(OH)D level below 40 ng/ml. In patients with vitamin D insufficiency or deficiency, a large replacing dose ...as, patients ’ compliance after the initial phase; a ... See full document
10
<p>Change in Functional Brain Activation Patterns Induced by Olfactory Stimulation in Multiple Sclerosis</p>
... olfactory dysfunction of ...MS patients was 11 – 50% (average: ...in patients with olfactory impairment in MS, 11 suggesting that the olfactory loop could be damaged from olfactory bulbs and tracts ... See full document
8
Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies
... The use of the osmotic agent lactulose should be cautious and used only in patients with very mild symptoms. In fact, given the likely presence of pan-gut dysmotility, it is likely to cause or aggravate symptoms ... See full document
<p>Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis</p>
... environment, social relationships, and embarrassment. The ABSST has a 4-point Likert scale (from 0 – 3; where 0 indicates no symptoms or impact; and 3 represent severe symptoms or large impact). The total ABSST score was ... See full document
5
<p>Dysphagia In Multiple Sclerosis Patients: Diagnostic And Evaluation Strategies</p>
... in patients with neurological ...of patients for dysphagia symptoms during eating solid food and drinking liquid to the instrumental techniques of video fl uoroscopy and ...practice, patients would ... See full document
14
<p>Electrical stimulation in the treatment of bladder dysfunction: technology update</p>
... Eight patients with Parkinson Disease and urinary symptoms such as urgency and increased frequency received inhibitory TMS over the motor cortex for 2 weeks at 1 ...Ten multiple sclerosis ... See full document
9
Prevalence, Severity of Pain in Patients with Multiple Sclerosis (MS)
... related to the legs (74%), back pain (59%), neck pain (52%) and shoulder pain (49%), respectively. Since little information is available on the possible causes of MS; therefore, studying the demographic characteristics ... See full document
6
Frequency of OSM in Patients with Relapsing-Remmiting Multiple Sclerosis
... Multiple Sclerosis (MS) is a chronic disease with an unknown cause that results in inflammation and destruction of Myelin in central nervous system ...in patients with multiple ...the ... See full document
7
IL-23R–activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity
... MS patients tended to have a higher sensitivity to IL-23, resulting in the phosphorylation of STAT3 and ...MS patients may inherently be more responsive to IL-23, which suggests that IL-23R may be a suscep- ... See full document
21
<p>Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain</p>
... Methods: A cross-sectional study was conducted with 157 MS patients with disease-modifying treatments. Adherence was assessed using the Morisky Green scale, and other related factors were measured using a ... See full document
12
<p>Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis</p>
... in patients with SSc-PAH, though preliminary data did not show statistical signi fi cance in improvement of the 6MW ...in patients with PAH including CTD- ... See full document
15
<p>Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS)</p>
... POMS patients on either natalizumab or fi ngolimod published in 2017, ana- lyzed relapse rate and MRI data (including T2-weighted and gadolinium-enhancing lesion number) prior to therapy initiation and at follow-up ... See full document
6
Comorbidity in US patients with multiple sclerosis
... in patients with MS was assessed by year (2006–2014), and logistic regression models evaluated the association of age, sex, and region with select ...of patients within an individual year), followed by ... See full document
6
Related subjects